Popular acid reflux drugs such as Prilosec, Nexium, and Protonix may carry hidden risks when taken long term. A new study ...
Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 ...
Bristol-Myers shares rise after Reblozyl study meets key goals in alpha-thalassemia patients, showing improved hemoglobin ...
Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...
It took a while for the science to basically catch up to that suspicion.” In these types of “recessive” conditions, the ...
Erika Prouty, PharmD, is a professional community pharmacist that specializes in blood cholesterol readings, blood pressure readings, and medication therapy management. B12 deficiency can cause ...
For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...
Intravenous iron treatments improve survival and hemoglobin levels in anemic patients with acute bacterial infections, except in meningitis cases. The study challenges the belief that iron infusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results